Viewing data from:

VOLNEA

ANDA

DESOGESTREL; ETHINYL ESTRADIOL | A202689 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CYCLESSA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.1493

per ea

Lowest NADAC/Unit

$0.1493

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70700012285VOLNEA 0.15-0.02-0.01 MG TAB	$0.1493	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

Medicare Part D Spending

CMS annual spending data for Volnea (2024)

Total Spending

$48K

Total Claims

1,841

Beneficiaries

525

Avg Cost/Unit

$0.48

Spending Trend

$17K(2020)→$47K(2021)→$64K(2022)→$81K(2023)→$48K(2024)

YoY Change:-32.8%

5yr CAGR:-15.5%

Source: CMS Medicare Part D Spending by Drug (2024). Shows gross drug cost under Part D.

Products (1)

#001 — 0.15MG,N/A;0.02MG,0.01MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Sep 9, 2016

No patent or exclusivity listings for this strength.